Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 83 of the 88 references it cites were found in a registry or an index; 26 of the 30 sources its claims cite were checked for support.

Bile salt hydrolases shape the bile acid landscape and restrict Clostridioides difficile growth in the murine gut

Open access

Abstract

Bile acids (BAs) mediate the crosstalk between human and microbial cells and influence diseases including Clostridioides difficile infection (CDI). While bile salt hydrolases (BSHs) shape the BA pool by deconjugating conjugated BAs, the basis for their substrate selectivity and impact on C. difficile remain elusive. Here we survey the diversity of BSHs in the gut commensals Lactobacillaceae, which are commonly used as probiotics, and other members of the human gut microbiome. We structurally pinpoint a loop that predicts BSH preferences for either glycine or taurine substrates. BSHs with varying specificities were shown to restrict C. difficile spore germination and growth in vitro and colonization in pre-clinical in vivo models of CDI. Furthermore, BSHs reshape the pool of microbial conjugated bile acids (MCBAs) in the murine gut, and these MCBAs can further restrict C. difficile virulence in vitro. The recognition of conjugated BAs by BSHs defines the resulting BA pool, including the expansive MCBAs. This work provides insights into the structural basis of BSH mechanisms that shape the BA landscape and promote colonization resistance against C. difficile.

Overview

CoChat Summary

## TL;DR

This paper shows that a 3-residue “selectivity loop” in bile salt hydrolases (BSHs) predicts whether enzymes prefer glycine or taurine conjugates, and that these enzymes can reshape bile acid pools in ways that restrict *Clostridioides difficile*. In mouse and ex vivo models, BSH cocktails reduced *C. difficile* spore germination and growth, and also increased microbial conjugated bile acids (MCBAs) that themselves affected *C. difficile* biology.

## Key findings

  • The authors surveyed 3,712 genomes from 274 Lactobacillaceae and grouped highly similar BSH sequences into 84 clusters; nearly all clusters were from vertebrate-adapted species and about 40% were human-associated.
  • Across the gut microbiome, they identified 654 unique BSH sequences from the Integrated Gene Catalog; 350 encoded the S-R-X loop, 87 encoded G-X-G, 141 lacked the loop, and the remainder were “Other,” with the loop present in about 67% of BSH proteins.
  • Structural and mutational work showed that the selectivity loop predicts substrate preference: taurine-preferring enzymes had G-X-G motifs, glycine-preferring enzymes had S-R-X motifs, and loop-swapping mutations reduced selectivity from 76-fold to 14-fold for LgasBSHa and from 353-fold to 2-fold for LgasBSHb.
  • In human pre-FMT stool samples from 6 rCDI recipients, BSH cocktails inhibited *C. difficile* growth in 4 of 6 samples at 8 h and/or 24 h; in mice, a BSH cocktail significantly inhibited *C. difficile* in the small intestine and caecum, though it did not alter clinical signs of disease or weight loss.
  • In cefoperazone-treated mice, the BSH cocktail increased deconjugated BAs and generated a diverse MCBA pool, with Ile-CA, Tyr-CA, Phe-CA, Arg-CA, and Lys-CA being most prominent.

## Methods

  • The study combined comparative genomics and phylogenetics, X-ray crystallography of six Lactobacillaceae BSHs, site-directed mutagenesis, and in vitro enzyme assays to link BSH sequence features to substrate specificity.
  • Functional testing used ex vivo stool and mouse intestinal content assays, C. difficile spore germination/growth assays, membrane integrity and reporter assays, plus targeted LC–IMS–MS bile acid metabolomics.
  • In vivo work used male C57BL/6J mice in a cefoperazone-treated CDI model; mice received a taurine-preferring BSH cocktail (LgasBSHa, LjohBSHc, LsalBSH), were challenged with 10^5 C. difficile spores, and were analyzed at day 2.

## Limitations

  • The paper states that BSHs were neither shown to impact clinical signs of disease in vivo nor tested as a treatment for CDI; this limits therapeutic claims.
  • The authors note that data collection was not randomized and analysis was not blinded, and that no statistical methods were used to pre-determine sample sizes.
  • The text makes evident that mouse bile acid biology is taurine-biased, which the authors say can limit translation to humans; this is an evident limitation from the study design.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41564-023-01337-7

Cites

83 of 83 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Lactobacillaceae BSHs have distinct substrate preferences. a, Overview of BA metabolism using CA as an example. BAs are synthesized and conjugated with a taurine or glycine (T/GCA) by the liver enzyme Baat. Conjugated BAs are deconjugated by BSHs, allowing transformations such as 7α-dehydroxylation encoded by the bai operon to generate secondary BAs such as DCA. Deconjugated BAs can be reconjugated to produce MCBAs such as Tyr-CA. b, The Lactobacillaceae BSH phylogenetic tree was assembled from 84 BSH clusters. The two major clades are distinguished by black and blue branches. Each cluster name indicates the BSH-encoding species, with the inner metadata layers indicating lifestyle and isolation source82. Beige wedges in the outer metadata layer indicate the BSHs cloned for characterization. c, Heat map of BSH activity across conjugated BAs. The clade highlighted in blue displays preference for taurine-conjugated BAs. Diamonds in b and c indicate BSH crystal structures presented here. Values represent mean specific activity (n = 3–4). Phylogenetic relationships between BSHs are based on amino acid sequences. d, Superposition of the taurine and glycine-preferring BSH enzyme tetramer crystal structures presented here. Source data
Fig. 1 Lactobacillaceae BSHs have distinct substrate preferences. a, Overview of BA metabolism using CA as an example. BAs are synthesized and conjugated with a taurine or glycine (T/GCA) by the liver enzyme Baat. Conjugated BAs are deconjugated by BSHs, allowing transformations such as 7α-dehydroxylation encoded by the bai operon to generate secondary BAs such as DCA. Deconjugated BAs can be reconjugated to produce MCBAs such as Tyr-CA. b, The Lactobacillaceae BSH phylogenetic tree was assembled from 84 BSH clusters. The two major clades are distinguished by black and blue branches. Each cluster name indicates the BSH-encoding species, with the inner metadata layers indicating lifestyle and isolation source82. Beige wedges in the outer metadata layer indicate the BSHs cloned for characterization. c, Heat map of BSH activity across conjugated BAs. The clade highlighted in blue displays preference for taurine-conjugated BAs. Diamonds in b and c indicate BSH crystal structures presented here. Values represent mean specific activity (n = 3–4). Phylogenetic relationships between BSHs are based on amino acid sequences. d, Superposition of the taurine and glycine-preferring BSH enzyme tetramer crystal structures presented here. Source dataCC BY · PubMed Central
Fig. 2 BSH selectivity loop sequence predicts substrate preference. a, Superimposed monomers of six BSH structures highlighting the substrate preference loop and coloured as indicated in b. b, Sequence alignment of the selectivity loop region of Lactobacillaceae BSHs. Resolved structures are uniquely coloured, with a constant colouring scheme throughout the figure. Taurine-preferring enzymes exhibit a G-V/T-G motif, while glycine-preferring enzymes maintain an S-R-G/S motif. c,d, Superposition of the active sites of either two taurine-preferring (c) or four glycine-preferring (d) BSH structures reveals a consistent active site architecture that accommodates taurine or glycine, respectively. e, Sequence similarity network (SSN) of BSHs reveals clustering by selectivity loop sequence. Lines connecting BSHs indicate relatedness. Bolded diamonds represent proteins selected for activity characterization. Sequences (689) were clustered by 95% sequence identity to yield 654 unique nodes (circles). f, Heat map of specific activities of a panel of BSH enzymes with 8 BA substrates shows that substrate specificity is predicted by selectivity loop sequence. Values in boxes represent mean specific activity from n = 3 replicates. g, The LgasBSHa tetramer with the active site shown in the inset, where the catalytic cysteine at position 2, the bound taurine and CDCA compounds, and the GVG swapped into the active site from the neighbouring monomer are highlighted. h, The LgasBSHb tetramer with the active site shown in the inset, where the catalytic cysteine at position 2 and the SRS swapped into the active site from the neighbouring monomer are highlighted. The taurine and CDCA ligands from the LgasBSHa structure are also rendered transparent. i,j, Specific activities for wild-type and mutant forms of LgasBSHa (i) and LgasBSHb (j) with GCA and TCA. Bars in i and j are the mean ± s.d. of n = 3. Significant differences were tested by two-way ANOVA with Tukey’s multiple comparisons test (NS, not significant; *P < 0.05, **P < 0.01, ****P < 0.0001). k,l, Ratios of TCA:GCA specific activity for LgasBSHa (k) and GCA:TCA specific activity for LgasBSHb (l). Bars in k and l are the mean ± s.d. of n = 3. Significant differences were tested by one-way ANOVA with Tukey’s multiple comparisons test. *P < 0.05, ****P < 0.0001. All P values are listed in Supplementary Data 1. Source data
Fig. 2 BSH selectivity loop sequence predicts substrate preference. a, Superimposed monomers of six BSH structures highlighting the substrate preference loop and coloured as indicated in b. b, Sequence alignment of the selectivity loop region of Lactobacillaceae BSHs. Resolved structures are uniquely coloured, with a constant colouring scheme throughout the figure. Taurine-preferring enzymes exhibit a G-V/T-G motif, while glycine-preferring enzymes maintain an S-R-G/S motif. c,d, Superposition of the active sites of either two taurine-preferring (c) or four glycine-preferring (d) BSH structures reveals a consistent active site architecture that accommodates taurine or glycine, respectively. e, Sequence similarity network (SSN) of BSHs reveals clustering by selectivity loop sequence. Lines connecting BSHs indicate relatedness. Bolded diamonds represent proteins selected for activity characterization. Sequences (689) were clustered by 95% sequence identity to yield 654 unique nodes (circles). f, Heat map of specific activities of a panel of BSH enzymes with 8 BA substrates shows that substrate specificity is predicted by selectivity loop sequence. Values in boxes represent mean specific activity from n = 3 replicates. g, The LgasBSHa tetramer with the active site shown in the inset, where the catalytic cysteine at position 2, the bound taurine and CDCA compounds, and the GVG swapped into the active site from the neighbouring monomer are highlighted. h, The LgasBSHb tetramer with the active site shown in the inset, where the catalytic cysteine at position 2 and the SRS swapped into the active site from the neighbouring monomer are highlighted. The taurine and CDCA ligands from the LgasBSHa structure are also rendered transparent. i,j, Specific activities for wild-type and mutant forms of LgasBSHa (i) and LgasBSHb (j) with GCA and TCA. Bars in i and j are the mean ± s.d. of n = 3. Significant differences were tested by two-way ANOVA with Tukey’s multiple comparisons test (NS, not significant; *P < 0.05, **P < 0.01, ****P < 0.0001). k,l, Ratios of TCA:GCA specific activity for LgasBSHa (k) and GCA:TCA specific activity for LgasBSHb (l). Bars in k and l are the mean ± s.d. of n = 3. Significant differences were tested by one-way ANOVA with Tukey’s multiple comparisons test. *P < 0.05, ****P < 0.0001. All P values are listed in Supplementary Data 1. Source dataCC BY · PubMed Central
Fig. 3 Deconjugated BAs and BSH activity can inhibit C. difficile. a, Schematic of in vitro BA-dependent inhibition of C. difficile germination and growth. b, Inhibition of spore germination using various BAs (0.75 mM) in the presence of the germinant TCA (2 mM). Comparisons were only made between BAs that share the same sterol core using one-way ANOVA with Tukey’s multiple comparisons test, except for the αMCA and βMCA BAs which were compared with one-tailed Welch’s t-test. c, Inhibition of C. difficile growth as determined by MIC testing. Bar colours in b and c are coded consistently on the basis of the BA conjugation indicated in a. d, Schematic of pre-FMT collection and ex vivo growth. Pre-FMT stool collected from rCDI patient was supplemented with PBS or a BSH cocktail and subsequently inoculated with C. difficile. Recipients 1–3 and 4–6 were inoculated with 105 and 106 c.f.u.s ml−1, respectively. e, C. difficile growth measured at 8 h. f, Targeted metabolomics showing CA from the samples in e. Statistical differences were tested by one-way ANOVA with Sidak’s correction for multiple comparisons. All bars represent mean ± s.d. of n = 3 replicates. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. All P values are listed in Supplementary Data 1. Source data
Fig. 3 Deconjugated BAs and BSH activity can inhibit C. difficile. a, Schematic of in vitro BA-dependent inhibition of C. difficile germination and growth. b, Inhibition of spore germination using various BAs (0.75 mM) in the presence of the germinant TCA (2 mM). Comparisons were only made between BAs that share the same sterol core using one-way ANOVA with Tukey’s multiple comparisons test, except for the αMCA and βMCA BAs which were compared with one-tailed Welch’s t-test. c, Inhibition of C. difficile growth as determined by MIC testing. Bar colours in b and c are coded consistently on the basis of the BA conjugation indicated in a. d, Schematic of pre-FMT collection and ex vivo growth. Pre-FMT stool collected from rCDI patient was supplemented with PBS or a BSH cocktail and subsequently inoculated with C. difficile. Recipients 1–3 and 4–6 were inoculated with 105 and 106 c.f.u.s ml−1, respectively. e, C. difficile growth measured at 8 h. f, Targeted metabolomics showing CA from the samples in e. Statistical differences were tested by one-way ANOVA with Sidak’s correction for multiple comparisons. All bars represent mean ± s.d. of n = 3 replicates. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. All P values are listed in Supplementary Data 1. Source dataCC BY · PubMed Central
Fig. 4 BSHs govern C. difficile spore germination and growth along the murine intestinal tract. a, Schematic of BSH-dependent inhibition of ex vivo C. difficile germination and growth. Intestinal contents collected from cefoperazone-treated mice were supplemented with a cocktail of BSHs and then inoculated with C. difficile spores or cells to measure germination or growth, respectively. b, Germination of C. difficile spores in murine small intestinal contents. Contents were treated with PBS or a BSH cocktail for 8 h before inoculation. c, Growth of C. difficile at 8 and 24 h in murine intestinal contents. Contents were treated with PBS or a BSH cocktail and inoculated simultaneously. Statistical differences were tested by one-tailed ratio paired t-test. d,e, Targeted metabolomics showing the BAs identified in the day 0 small intestinal samples from c. Statistical differences were assessed by one-tailed t-test. Bars represent mean ± s.d. (n = 4). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. All P values are listed in Supplementary Data 1. Source data
Fig. 4 BSHs govern C. difficile spore germination and growth along the murine intestinal tract. a, Schematic of BSH-dependent inhibition of ex vivo C. difficile germination and growth. Intestinal contents collected from cefoperazone-treated mice were supplemented with a cocktail of BSHs and then inoculated with C. difficile spores or cells to measure germination or growth, respectively. b, Germination of C. difficile spores in murine small intestinal contents. Contents were treated with PBS or a BSH cocktail for 8 h before inoculation. c, Growth of C. difficile at 8 and 24 h in murine intestinal contents. Contents were treated with PBS or a BSH cocktail and inoculated simultaneously. Statistical differences were tested by one-tailed ratio paired t-test. d,e, Targeted metabolomics showing the BAs identified in the day 0 small intestinal samples from c. Statistical differences were assessed by one-tailed t-test. Bars represent mean ± s.d. (n = 4). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. All P values are listed in Supplementary Data 1. Source dataCC BY · PubMed Central
Fig. 5 BSHs inhibit C. difficile and enrich the MCBA pool in vivo. a, Schematic of BSH delivery in a mouse model of CDI. The colour code in this legend corresponds to the test conditions in b and c. b, C. difficile c.f.u.s in infected mouse intestinal contents. These data are pooled and the white and grey dots represent separate independent experiments. Bars represent mean ± s.d. (n = 10 and 13 for Cd + PBS and Cd + BSH, respectively). Statistical differences were assessed by one-tailed Mann-Whitney test. c, Targeted metabolomics showing small intestinal BAs from mice in b. Statistical differences were tested by Kruskal-Wallis with Dunn’s test for multiple comparisons. d, Targeted metabolomic heat map showing small intestinal MCBAs identified from mice in b. MCBAs are organized by unsupervised hierarchical clustering. MCBA abundances are represented as colours corresponding to log10-transformed peak areas. e, Heat map of select BSH activity across all MCBA pools. Values represent the mean from n = 3 replicates of % deconjugation after 5 min. f, Inhibition of C. difficile germination with MCBAs (0.75 mM) in the presence of the germinant TCA (2 mM). Statistical differences were tested by one-way ANOVA with Dunnett’s test for multiple comparisons. g, Growth of C. difficile in the presence of 0.75 mM MCBAs. h, MCBA regulation of toxin expression using a PtcdA-mCherry reporter. Statistical differences were assessed by one-way ANOVA with Dunnett’s test for multiple comparisons. Data in f–h represent mean ± s.d. (n = 3–4). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. All P values are listed in Supplementary Data 1. Source data
Fig. 5 BSHs inhibit C. difficile and enrich the MCBA pool in vivo. a, Schematic of BSH delivery in a mouse model of CDI. The colour code in this legend corresponds to the test conditions in b and c. b, C. difficile c.f.u.s in infected mouse intestinal contents. These data are pooled and the white and grey dots represent separate independent experiments. Bars represent mean ± s.d. (n = 10 and 13 for Cd + PBS and Cd + BSH, respectively). Statistical differences were assessed by one-tailed Mann-Whitney test. c, Targeted metabolomics showing small intestinal BAs from mice in b. Statistical differences were tested by Kruskal-Wallis with Dunn’s test for multiple comparisons. d, Targeted metabolomic heat map showing small intestinal MCBAs identified from mice in b. MCBAs are organized by unsupervised hierarchical clustering. MCBA abundances are represented as colours corresponding to log10-transformed peak areas. e, Heat map of select BSH activity across all MCBA pools. Values represent the mean from n = 3 replicates of % deconjugation after 5 min. f, Inhibition of C. difficile germination with MCBAs (0.75 mM) in the presence of the germinant TCA (2 mM). Statistical differences were tested by one-way ANOVA with Dunnett’s test for multiple comparisons. g, Growth of C. difficile in the presence of 0.75 mM MCBAs. h, MCBA regulation of toxin expression using a PtcdA-mCherry reporter. Statistical differences were assessed by one-way ANOVA with Dunnett’s test for multiple comparisons. Data in f–h represent mean ± s.d. (n = 3–4). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. All P values are listed in Supplementary Data 1. Source dataCC BY · PubMed Central
Extended Data Fig. 1 Structural and sequence comparisons of Lactobacillaceae BSHs. (A) Full tetrameric structures of the crystal structures presented here and colored as indicated in Fig. 2B (B) Root-mean square deviation (RMSD) in Å across equivalent Cα positions for the crystal structures presented, as well as % sequence identity values.
Extended Data Fig. 1 Structural and sequence comparisons of Lactobacillaceae BSHs. (A) Full tetrameric structures of the crystal structures presented here and colored as indicated in Fig. 2B (B) Root-mean square deviation (RMSD) in Å across equivalent Cα positions for the crystal structures presented, as well as % sequence identity values.CC BY · PubMed Central
Extended Data Fig. 2 Bile acid impacts on C. difficile biology. A) Germination of C. difficile carried out using 2 mM BAs as the sole germinant. (B) Propidium iodide staining of exponentially growing C. difficile after a 30 min exposure to BAs (n = 3). Bars from A and B represent mean biological replicates (n = 3) ± standard deviation. Conventional BAs and Trp-CDCA concentrations were 0.25x their MIC except the MCBAs which were used at 0.5 mM. The detergent SDS (150 μM) was used as a positive control for detergent-induced membrane damage. Comparisons were only made between BAs that share the same BA sterol core using a one-way ANOVA with Dunnett’s multiple comparisons test except for αMCA and TαMCA which were compared with a one-tailed Welch’s t test. (C) BA regulation of tcdA expression using a PtcdA-mCherry reporter31. C. difficile was grown for 24 in the presence of the conventional BAs and Trp-CDCA at 0.25x their MIC whereas the MCBAs were used at 0.5 mM. Bars represent mean biological replicates (n = 4) ± standard deviation. BAs conditions were compared to BHIS or MeOH (BHIS media with methanol) based on the BA’s solvent using a one-way ANOVA with Dunnett’s multiple comparisons test. Asterisks indicate significant differences (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001). All p values listed in Supplementary Data 1. Bars are color coded as follows: teal = taurine conjugation, pink = glycine conjugation, red = deconjugated, beige = MCBA, grey = no BA. Source data
Extended Data Fig. 2 Bile acid impacts on C. difficile biology. A) Germination of C. difficile carried out using 2 mM BAs as the sole germinant. (B) Propidium iodide staining of exponentially growing C. difficile after a 30 min exposure to BAs (n = 3). Bars from A and B represent mean biological replicates (n = 3) ± standard deviation. Conventional BAs and Trp-CDCA concentrations were 0.25x their MIC except the MCBAs which were used at 0.5 mM. The detergent SDS (150 μM) was used as a positive control for detergent-induced membrane damage. Comparisons were only made between BAs that share the same BA sterol core using a one-way ANOVA with Dunnett’s multiple comparisons test except for αMCA and TαMCA which were compared with a one-tailed Welch’s t test. (C) BA regulation of tcdA expression using a PtcdA-mCherry reporter31. C. difficile was grown for 24 in the presence of the conventional BAs and Trp-CDCA at 0.25x their MIC whereas the MCBAs were used at 0.5 mM. Bars represent mean biological replicates (n = 4) ± standard deviation. BAs conditions were compared to BHIS or MeOH (BHIS media with methanol) based on the BA’s solvent using a one-way ANOVA with Dunnett’s multiple comparisons test. Asterisks indicate significant differences (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001). All p values listed in Supplementary Data 1. Bars are color coded as follows: teal = taurine conjugation, pink = glycine conjugation, red = deconjugated, beige = MCBA, grey = no BA. Source dataCC BY · PubMed Central
Extended Data Fig. 3 Bile acid metabolomics of BSH-treated pre-FMT stool. (A) Targeted metabolomics showing all detected BAs at 8 h in pre-FMT stool samples. Bars represent mean (n = 3) ± standard deviation. Asterisks indicate significant differences (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001) from PBS by one-way ANOVA with Sidak’s correction for multiple comparisons. All p values listed in Supplementary Data 1. (B) Untargeted metabolomic analysis of antibiotics detected in pre-FMT fecal samples. Vancomycin was detected in all three samples that were most inhibitory to C. difficile even in the PBS control condition. Source data
Extended Data Fig. 3 Bile acid metabolomics of BSH-treated pre-FMT stool. (A) Targeted metabolomics showing all detected BAs at 8 h in pre-FMT stool samples. Bars represent mean (n = 3) ± standard deviation. Asterisks indicate significant differences (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001) from PBS by one-way ANOVA with Sidak’s correction for multiple comparisons. All p values listed in Supplementary Data 1. (B) Untargeted metabolomic analysis of antibiotics detected in pre-FMT fecal samples. Vancomycin was detected in all three samples that were most inhibitory to C. difficile even in the PBS control condition. Source dataCC BY · PubMed Central
Extended Data Fig. 4 C. difficile growth in pre-FMT stool. Growth was measured at 8 and 24 h from an n = 3 replicates. Targeted metabolomics showing the deconjugated BAs CA and CDCA from the samples from. Bars represent mean ± standard deviation. Asterisks indicate significant differences (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001) between CFUs by one-way ANOVA with Sidak’s correction for multiple comparisons. All p values listed in Supplementary Data 1. Source data
Extended Data Fig. 4 C. difficile growth in pre-FMT stool. Growth was measured at 8 and 24 h from an n = 3 replicates. Targeted metabolomics showing the deconjugated BAs CA and CDCA from the samples from. Bars represent mean ± standard deviation. Asterisks indicate significant differences (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001) between CFUs by one-way ANOVA with Sidak’s correction for multiple comparisons. All p values listed in Supplementary Data 1. Source dataCC BY · PubMed Central
Extended Data Fig. 5 Bile acid metabolomics of C. difficile spore germination and growth in mouse intestinal content. Asterisks indicate significant differences (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001) between treatments by ratio paired one-tailed t test. Bars represent mean ± standard deviation from n = 4 samples. All p values listed in Supplementary Data 1. Source data
Extended Data Fig. 5 Bile acid metabolomics of C. difficile spore germination and growth in mouse intestinal content. Asterisks indicate significant differences (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001) between treatments by ratio paired one-tailed t test. Bars represent mean ± standard deviation from n = 4 samples. All p values listed in Supplementary Data 1. Source dataCC BY · PubMed Central
Extended Data Fig. 6 Cecal MCBA pool in BSH treated mice. Targeted metabolomics showing cecal MCBAs identified from mice in Fig. 5B. MCBAs have been Log10 transformed and are organized by unsupervised hierarchical clustering. Source data
Extended Data Fig. 6 Cecal MCBA pool in BSH treated mice. Targeted metabolomics showing cecal MCBAs identified from mice in Fig. 5B. MCBAs have been Log10 transformed and are organized by unsupervised hierarchical clustering. Source dataCC BY · PubMed Central
Extended Data Fig. 7 BSH activity with pure MCBAs. Heatmaps of BSH specific activity using pure MCBAs. Values represent mean activity (n = 3). BSHs were arranged into a phylogeny based on their amino acid sequence. The ability to process penV was included as a potential BSH substrate. Source data
Extended Data Fig. 7 BSH activity with pure MCBAs. Heatmaps of BSH specific activity using pure MCBAs. Values represent mean activity (n = 3). BSHs were arranged into a phylogeny based on their amino acid sequence. The ability to process penV was included as a potential BSH substrate. Source dataCC BY · PubMed Central
Extended Data Fig. 8 Broadly surveying BSH processing of MCBAs. (A) Schematic of BSH reactions with pooled MCBAs. Individual BSHs were reacted with pooled BA over an hour. Reactions were halted and BA abundance was quantified using LC-IMS-MS targeted BA metabolomics to measure deconjugation over time. (B) A heatmap of BSH activity across all MCBA pools. Values represent the mean from n = 3 replicates of % deconjugation after 5 minutes, which was calculated by measuring the abundance of an individual BA at 0 m and 5 m to quantify the proportion of substrate deconjugated. (C) A heatmap of L. gasseri BSH activity after 1 h. Source data
Extended Data Fig. 8 Broadly surveying BSH processing of MCBAs. (A) Schematic of BSH reactions with pooled MCBAs. Individual BSHs were reacted with pooled BA over an hour. Reactions were halted and BA abundance was quantified using LC-IMS-MS targeted BA metabolomics to measure deconjugation over time. (B) A heatmap of BSH activity across all MCBA pools. Values represent the mean from n = 3 replicates of % deconjugation after 5 minutes, which was calculated by measuring the abundance of an individual BA at 0 m and 5 m to quantify the proportion of substrate deconjugated. (C) A heatmap of L. gasseri BSH activity after 1 h. Source dataCC BY · PubMed Central
Extended Data Fig. 9 LingBSH deconjugation kinetics of MCBAs. LingBSH-catalyzed deconjugation of MCBAs at 5, 30, and 60 min. Lines are plotted from mean from a n = 3 replicates. Source data
Extended Data Fig. 9 LingBSH deconjugation kinetics of MCBAs. LingBSH-catalyzed deconjugation of MCBAs at 5, 30, and 60 min. Lines are plotted from mean from a n = 3 replicates. Source dataCC BY · PubMed Central
Extended Data Fig. 10 C. difficile growth and spore germination with MCBAs. Germination of C. difficile was carried out using 2 mM BAs. (B) Germination inhibition with the germinant TCA (2 mM) was carried out with 0.75 mM MCBA. Bars from A and B represent mean (n = 3) ± standard deviation. Bars are color coded as follows: teal = taurine conjugation, pink = glycine conjugation, red = deconjugated, beige = MCBA, grey = no BA. (C) Growth was carried out in the presence of 2 mM BAs in triplicate. Data represent mean ± standard deviation. Trp-CDCA inhibited growth at this concentration and its MIC was determined to be 0.5 mM. Asterisks indicate significant differences (***p < 0.001, ****p < 0.0001) from TCA only by one-way ANOVA with Sidak’s correction for multiple comparisons. Germination of C. difficile was carried out using 2 mM BAs. (B) Germination inhibition with the germinant TCA (2 mM) was carried out with 0.75 mM MCBA. Bars from A and B represent mean (n = 3) ± standard deviation. Bars are color coded as follows: teal = taurine conjugation, pink = glycine conjugation, red = deconjugated, beige = MCBA, grey = no BA. (C) Growth was carried out in the presence of 2 mM BAs in triplicate. Data represent mean ± standard deviation. Trp-CDCA inhibited growth at this concentration and its MIC was determined to be 0.5 mM. Asterisks indicate significant differences (***p < 0.001, ****p < 0.0001) from TCA only by one-way ANOVA with Sidak’s correction for multiple comparisons. Source data
Extended Data Fig. 10 C. difficile growth and spore germination with MCBAs. Germination of C. difficile was carried out using 2 mM BAs. (B) Germination inhibition with the germinant TCA (2 mM) was carried out with 0.75 mM MCBA. Bars from A and B represent mean (n = 3) ± standard deviation. Bars are color coded as follows: teal = taurine conjugation, pink = glycine conjugation, red = deconjugated, beige = MCBA, grey = no BA. (C) Growth was carried out in the presence of 2 mM BAs in triplicate. Data represent mean ± standard deviation. Trp-CDCA inhibited growth at this concentration and its MIC was determined to be 0.5 mM. Asterisks indicate significant differences (***p < 0.001, ****p < 0.0001) from TCA only by one-way ANOVA with Sidak’s correction for multiple comparisons. Germination of C. difficile was carried out using 2 mM BAs. (B) Germination inhibition with the germinant TCA (2 mM) was carried out with 0.75 mM MCBA. Bars from A and B represent mean (n = 3) ± standard deviation. Bars are color coded as follows: teal = taurine conjugation, pink = glycine conjugation, red = deconjugated, beige = MCBA, grey = no BA. (C) Growth was carried out in the presence of 2 mM BAs in triplicate. Data represent mean ± standard deviation. Trp-CDCA inhibited growth at this concentration and its MIC was determined to be 0.5 mM. Asterisks indicate significant differences (***p < 0.001, ****p < 0.0001) from TCA only by one-way ANOVA with Sidak’s correction for multiple comparisons. Source dataCC BY · PubMed Central

Verification

Claims the paper makes

14 Valid · 0 Not valid · 2 Not checked · 113 Own results and interpretations

61 more claims · 2 with their cited sources checked

Create a free account to see all 129 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 36
  • Probably not a substantial claim. 32
  • The quote only partly states this claim. 2

Create a free account to see these claims.

Citations

Cites

Show all 88 references

Cited by

See all 181

Metadata

Authors
Foley, M. H., Walker, M. E., Stewart, A. K., O’Flaherty, S., Gentry, E. C., Patel, S., Beaty, V. V., Allen, G., Pan, M., Simpson, J. B., Perkins, C., Vanhoy, M. E., Dougherty, M. K., McGill, S. K., Gulati, A. S., Dorrestein, P. C., Baker, E. S., Redinbo, M. R., Barrangou, R., & Theriot, C. M.
Affiliations
  • North Carolina State University (US)
  • University of North Carolina at Chapel Hill (US)
  • University of California San Diego (US)
Corresponding author
  • Redinbo, Matthew R.
  • Barrangou, Rodolphe
  • Theriot, Casey M.
Venue
Nature Microbiology
Published
2023-03-13
Volume
8
Issue
4
Pages
611-628
ISSN
2058-5276 (ISSN-L)
OpenAlex
W4324129924
Cited by
181
References
88
Citations by year
2026: 50 · 2025: 56 · 2024: 56 · 2023: 19
FWCI
37.25
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Microbiology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
  • UNC Libraries
Funders
  • NCTraCS Translational and Clinical Sciences Institute Pilot Award UNCSUR11609 and Funding from IFF.
  • U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (T32GM008570)
  • U.S. Department of Health & Human Services | NIH | National Institute of Environmental Health Sciences (P42 ES027704)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Keywords
bile salt hydrolase, bile acids, Clostridium difficile infection, bile acid conjugates, Lactobacillaceae, substrate specificity, spore germination, colonization resistance, gut microbiota, probiotics, virulence
MeSH terms
Clostridioides, Amidohydrolases, Animals, Bile Acids and Salts, Clostridium Infections, Humans, Clostridioides difficile, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Bile salt hydrolases shape the bile acid landscape and restrict Clostridioides difficile growth in the murine gut. https://app.cochat.ai/papers/10.1038/s41564-023-01337-7
The paper
Foley, M. H., Walker, M. E., Stewart, A. K., O’Flaherty, S., Gentry, E. C., Patel, S., Beaty, V. V., Allen, G., Pan, M., Simpson, J. B., Perkins, C., Vanhoy, M. E., Dougherty, M. K., McGill, S. K., Gulati, A. S., Dorrestein, P. C., Baker, E. S., Redinbo, M. R., Barrangou, R., & Theriot, C. M. (2023). Bile salt hydrolases shape the bile acid landscape and restrict Clostridioides difficile growth in the murine gut. Nature Microbiology. https://doi.org/10.1038/s41564-023-01337-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.